Therapeutic Erythrocytapheresis (TE) versus Phlebotomy (P) in the treatment of Hereditary Hemochromatosis (HH) patients: Preliminary results from an ongoing randomized clinical trial (NCT 00202436)

E. Rombout Sestrienkova*, P.A. Noord, E. Reuser, J. Heeremans, Cees Th B.M. van Deursen, M. Janssen, G.H. Koek

*Corresponding author for this work

    Research output: Contribution to journalComment/Letter to the editorAcademicpeer-review

    Original languageEnglish
    Pages (from-to)135-136
    JournalTransfusion and Apheresis Science
    Issue number2
    Publication statusPublished - 1 Jan 2009

    Cite this